ZERO - The Project to End Prostate Cancer
ABOUT PROSTATE CANCERGET INVOLVEDPROGRAMSRESEARCHPARTNERSSTOREABOUT US
Risk Factors
Prevention
Detection
Diagnosis
Treatment
New Prostate Cancer Research
Prostate Cancer Resources
Managing Bone Metastases and Pain
Side Effects of Prostate Cancer Treatment

Smoking Linked to Prostate Cancer

Reuters Health | 01.27.2006

Smoking influences progression and prognosis of prostate cancer through a process called aberrant hypermethylation of CpG (cytosine-phosphorothiolated guanine) sequences on related genes, a new study indicates.

Previous studies have shown a positive association between current smoking and prostate carcinoma, as well as between aberrant CpG methylation profiles of certain gene promoters and progression of prostate cancer. But the mechanism involved in these associations had not been elucidated.

Dr. Rajvir Dahiya of the Veterans Affairs Medical Center and University of California, San Francisco, and his colleagues conducted a study involving 164 prostate cancer patients (52 current, 30 former, and 82 never smokers) and 69 patients with benign prostatic hyperplasia.

The investigators examined methylation in 3 genes that they have previously studied: adenomatous polyposis coli (APC), glutathione S-transferase pi (GSTP1), and multidrug resistance 1 (MDR1). They defined a methylation score (M-score) for each sample and related it to smoking status and outcomes.

The team found that the M-score was significantly higher in current smokers than in never smokers and also found a significant correlation between pack-years of smoking and M-score in the cancer patients. In addition, they noted a significant correlation of M-score with advanced pathologic features.

The researchers conclude that smoking may influence tumor progression through CpG hypermethylation of related genes in a dose-dependent fashion.

Cancer 2006;106:79-86

Reuters Health Information 2006. © 2006 Reuters Ltd.
Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 

All active news articles
About Prostate Cancer  |  Donate  |  Get Involved  |  Programs  |  Research   |  Partners  |  Store  |  About Us  |  Site Map  |  Contact Us  |  Privacy PolicySubscribe to the ZERO Prostate Cancer News Feed  

© Copyright 2010, ZERO - The Project to End Prostate Cancer. All rights reserved.

ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health
service provider. If you have problems with the site or need more information, please call us at 1.888.245.9455 or e-mail your comments. All names, logos and articles
are the copyrights of the respective owners.